The Intelligent Enterprise: Life Sciences
For life sciences companies, embracing the opportunities presented by new technologies and implementing the right business initiatives will form the foundation for a successful digital strategy to stay ahead of the innovation curve.
This white paper from SAP explores four major trends that are reshaping the life sciences industry:
- Sustainability: Increasing numbers of regulations focused on sustainability will force life sciences organizations to expand their sustainability efforts, where they will need to show how they contribute to overall sustainability efforts to demonstrate their value outside of the medications they develop.
- Empowered patients and personalization: Patients are increasingly taking control of their health approaches and are demanding therapies that provide promised outcomes. Personalized medicines are emerging at faster rates, with higher price points and improved patient results. Being able to provide outcome-based patient engagements and connect with patients directly becomes paramount.
- Big Data driving health networks: The need to provide therapeutic outcomes at lower costs is transitioning traditional, fragmented value chains to new ecosystems that integrate suppliers, contractors, and regulatory agencies.
- Regulatory pressures and rising healthcare costs: As public health issues continue to arise – with their associated impact on healthcare costs – regulatory pressures will continue. Unsustainable healthcare costs are driven by complex channel models and R&D investments. Costs that outpace GDP are constantly scrutinized. Energy, health, and sustainability compliance laws steadily increase and vary from country to country.